The Economic Burden of Metabolic Syndrome in Elective Surgery: An Australian Cost‐of‐Illness Study
ANZ Journal of Surgery · 2026-05 · 96 (5) · 1343-1349
DOI: 10.1111/ans.70588 ↗At a glance
Journal article in ANZ Journal of Surgery, published online on 2026-03-20. Written by Philip Norris and 7 co-authors. Institution: School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia. Major MEDLINE topics: Metabolic Syndrome, Elective Surgical Procedures, Cost of Illness, Postoperative Complications. Cited 1 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Australian Government Higher Degree Scholarship.
Abstract (original language)
Background
Metabolic syndrome (MetS) is common in elective surgical populations and is associated with increased postoperative complications. The national economic burden of MetS‐attributable surgical morbidity in Australia has not been quantified.
Methods
A prevalence‐based cost‐of‐illness model was constructed using Australian elective surgery volume data from the Australian Institute of Health and Welfare (2.3 million admissions, 2021–2022). MetS prevalence was modelled at 35% (sensitivity range 25%–46%). Complication risks were derived from a systematic review and meta‐analysis of over 13 million surgical patients. Excess direct hospital costs were estimated from an Australian public hospital system perspective for surgical site infections, cardiovascular events, 30‐day readmissions, and extended length of stay. Unit costs were obtained from the National Hospital Cost Data Collection and the Independent Hospital Pricing Authority, reported in 2023 Australian dollars. Deterministic sensitivity analysis tested model robustness.
Results
The annual cost burden attributable to MetS was AUD 1.98 billion (95% CI: AUD 1.32–2.64 billion). Costs were driven primarily by extended length of stay (AUD 1.15 billion), followed by readmissions (AUD 345 million), cardiovascular events (AUD 243 million), and surgical site infections (AUD 242 million). Costs ranged from AUD 1.32 billion at 25% prevalence to AUD 2.64 billion at 46% prevalence. The mean additional cost per MetS surgical patient was AUD 2460.
Conclusion
MetS imposes a substantial direct hospital cost burden on the Australian public hospital system. These findings support evaluation of routine preoperative MetS screening and optimisation strategies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Nursing and Midwifery, University of Southern Queensland, Toowoomba, Australia.
- School of Health, University of the Sunshine Coast, Sippy Downs, Australia.
- School of Accounting, Economics and Finance, University of KwaZulu-Natal, Durban, South Africa.
- St Andrew's Toowoomba Hospital, Toowoomba, Australia.
- Sunshine Coast Orthopaedic Group, Sunshine Coast University Private Hospital, Birtinya, Australia.
ORCID profiles: Philip Norris, Jeff Gow, Thomas Arthur, Daevyd Rodda, Florin Oprescu, Stephen Neville, Nicholas Ralph
Funding
- Australian Government Higher Degree Scholarship
Cite
APA
Norris, P., Gow, J., Arthur, T., Rodda, D., Coory, J., Oprescu, F., Neville, S., & Ralph, N. (2026). The Economic Burden of Metabolic Syndrome in Elective Surgery: An Australian Cost‐of‐Illness Study. ANZ Journal of Surgery, 96(5), 1343-1349. https://doi.org/10.1111/ans.70588
Vancouver
Norris P, Gow J, Arthur T, Rodda D, Coory J, Oprescu F, et al. The Economic Burden of Metabolic Syndrome in Elective Surgery: An Australian Cost‐of‐Illness Study. ANZ Journal of Surgery. 2026;96(5):1343-1349. doi:10.1111/ans.70588
BibTeX
@article{Norris2026,
author = {Norris, Philip and Gow, Jeff and Arthur, Thomas and Rodda, Daevyd and Coory, Joseph and Oprescu, Florin and Neville, Stephen and Ralph, Nicholas},
title = {The Economic Burden of Metabolic Syndrome in Elective Surgery: An Australian Cost‐of‐Illness Study},
journal = {ANZ Journal of Surgery},
year = {2026},
volume = {96},
number = {5},
pages = {1343--1349},
doi = {10.1111/ans.70588}
}
EUVIMED